Documentos de Faria N.R. | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Palabras Claves: "SARS-COV-2"

Subtipo de publicación

Publisher

Cell Host and Microbe(1)

Clinical Infectious Diseases(1)

Virus Evolution(1)

Área temáticas

Enfermedades(2)

Farmacología y terapéutica(1)

Medicina forense; incidencia de enfermedades(1)

Salud y seguridad personal(1)

Área de conocimiento

Epidemiología(1)

Farmacología(1)

Microbiología(1)

Año de Publicación

Origen

Palabras Claves

Molecular epidemiology(2)

phylogenetics(2)

Phylogeography(1)

Recombination(1)

Transmission lineages(1)

Genomic epidemiology of SARS-CoV-2 transmission lineages in Ecuador

Abstract: Characterisation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic diversity t

Palabras claves:

Molecular epidemiology, phylogenetics, Phylogeography, SARS-COV-2, Transmission lineages

Andrade-Molina D.M., Andrés Carrazco-Montalvo, Belén Prado-Vivar, Bernardo M. Gutierrez, Brünink S., Bruno A., Coloma J., da Silva Candido D., de Mora D., Drexler J.F., du Plessis L., Escalera-Zamudio M., Faria N.R., Fernandez-Cadena J.C., Gabriel Morey León, Gabriel Trueba, Juan José Guadalupe, Kraemer M.U.G., Kühne A., Manuel V. Gónzalez, McCrone J.T., Mestanza O., Michelle Grunauer Andrade, Mónica Becerra-Wong, Moreira-Soto A., Olmedo M., Orlando S.A., Patino L., Patricio Rojas-Silva, Paul Andres Cardenas, Paul Cardenas, Portugal D., Pybus O.G., Rubén Armas-Gonzalez, Sander A.L., Sevillano G., Sully Márquez, Verónica Barragán, Zurita Jeannete

Emergence and widespread circulation of a recombinant SARS-CoV-2 lineage in North America

Abstract: Although recombination is a feature of coronavirus evolution, previously detected recombinant lineag

Palabras claves:

Molecular epidemiology, phylogenetics, Recombination, SARS-COV-2

Bernardo M. Gutierrez, Castelán-Sánchez H.G., da Silva Candido D., Delaye L., Escalera-Zamudio M., Faria N.R., Fleishon S., Houzet R., Jackson B., Pybus O.G., Rambaut A., Ruis C.

Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: A Modelling Analysis

Abstract: Background. The public health impact of the coronavirus disease 2019 (COVID-19) pandemic has motivat

Palabras claves:

covid-19, epidemiology, modelling, SARS-COV-2, therapeutics

Alvarez-Moreno C.A., Angkasekwinai N., Boonyasiri A., Chanda D., Charoenpong L., Chayakulkeeree M., Cooke G.S., Costa S.F., Croda J., Cucunubá Z.M., Djaafara B.A., Esteban Ortiz-Prado, Estofolete C.F., Faria N.R., Forero-Peña D.A., Ghani A.C., Gibb D.M., Gordon A.C., Grillet M.E., Hallett T.B., Hamers R.L., Hamlet A., Irawany V., Jitmuang A., Keurueangkul N., Kimani T.N., Lampo M., Levin A.S., Lopardo G., Mustafa R., Nayagam S., Ngamprasertchai T., Njeri N.I.H., Nogueira M.L., Perroud M.W., Phillips A.N., Promsin P., Qavi A., Rodger A.J., Sabino E.C., Sangkaew S., Sari D., Sirijatuphat R., Sposito A.C., Srisangthong P., Thompson H.A., Triana L.C., Udwadia Z.F., Valderrama-Beltrán S.L., Walker P.G.T., Watson O.J., Whittaker C., Winskill P.